Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Apr 18, 2012

Mylan Pledges $500M to Expand Operations in Ireland Over Five Years

  • Mylan will invest up to $100 million a year over the next five years into expanding operations at its Galway and Dublin sites in Ireland, including enlarging R&D and manufacturing capacity within its respiratory, injectables, and oral solids franchises. Over 500 new jobs will be created, adding to the 700 employees Mylan already has in Ireland, where its Gerard Laboratories and Bioniche Pharma operations are based.

    The planned expansion of will be supported through financial incentives provided by the Irish government’s foreign investment agency IDA. “This investment in Mylan’s Irish operations and the growth of our capabilities in the country demonstrate our continued commitment to and confidence in our respiratory franchise and injectable platform, both of which are among Mylan’s many long-term growth drivers,” comments CEO Heather Bresch. “Ireland has also proven to be a valuable location for Mylan, providing the company with access to a skilled and highly educated workforce.” 

Related content


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

What Does Brexit Mean for Biotech?

Do you agree with the contention that Brexit will NOT have a long-term negative impact on the British biotech industry?

More »